Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
European Journal of Pharmacology
|
September 21, 2017
In-vitro and in-vivo studies supporting the therapeutic potential of ZP3022 in diabetes
Jolanta Skarbaliene, Kristoffer T Rigbolt, Keld Fosgerau, et al.
BMC Gastroenterology
|
March 22, 2023
Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal regenerative effects in an experimental model of inflammatory bowel disease in rats
Jolanta Skarbaliene, Jesper Mosolff Mathiesen, Bjarne Due Larsen, et al.
Peptides
|
April 8, 2015
The anti-diabetic effects of GLP-1-gastrin dual agonist ZP3022 in ZDF rats
Jolanta Skarbaliene, Thomas Secher, Jacob Jelsing, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
November 25, 2017
Modeling energy intake and body weight effects of a long-acting amylin analogue
Annika Brings, Jens Markus Borghardt, Jolanta Skarbaliene, et al.
Journal of Medicinal Chemistry
|
January 24, 2025
Creating Glepaglutide, the First Long-Acting GLP-2 Analogue to Enable a Ready-to-Use Injection
Bjarne Due Larsen, Jesper Skodborg Villadsen, Jolanta Skarbaliene, et al.
Annals of the New York Academy of Sciences
|
May 17, 2022
The dual GLP-1 and GLP-2 receptor agonist dapiglutide promotes barrier function in murine short bowel
Johannes Reiner, Johanna Thiery, Jascha Held, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
July 14, 2021
The long-acting amylin/calcitonin receptor agonist ZP5461 suppresses food intake and body weight in male rats
Lauren M Stein, Lauren E McGrath, Rinzin Lhamo, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
October 27, 2021
Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowel
Johannes Reiner, Peggy Berlin, Jascha Held, et al.
Journal of Medicinal Chemistry
|
November 11, 2025
Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin Analogue
Henrik Fischer Munch, Rasmus Just, Jesper Mosolff Mathiesen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
European Journal of Pharmacology
|
September 21, 2017
In-vitro and in-vivo studies supporting the therapeutic potential of ZP3022 in diabetes
Jolanta Skarbaliene, Kristoffer T Rigbolt, Keld Fosgerau, et al.
BMC Gastroenterology
|
March 22, 2023
Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal regenerative effects in an experimental model of inflammatory bowel disease in rats
Jolanta Skarbaliene, Jesper Mosolff Mathiesen, Bjarne Due Larsen, et al.
Peptides
|
April 8, 2015
The anti-diabetic effects of GLP-1-gastrin dual agonist ZP3022 in ZDF rats
Jolanta Skarbaliene, Thomas Secher, Jacob Jelsing, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
November 25, 2017
Modeling energy intake and body weight effects of a long-acting amylin analogue
Annika Brings, Jens Markus Borghardt, Jolanta Skarbaliene, et al.
Journal of Medicinal Chemistry
|
January 24, 2025
Creating Glepaglutide, the First Long-Acting GLP-2 Analogue to Enable a Ready-to-Use Injection
Bjarne Due Larsen, Jesper Skodborg Villadsen, Jolanta Skarbaliene, et al.
Annals of the New York Academy of Sciences
|
May 17, 2022
The dual GLP-1 and GLP-2 receptor agonist dapiglutide promotes barrier function in murine short bowel
Johannes Reiner, Johanna Thiery, Jascha Held, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
July 14, 2021
The long-acting amylin/calcitonin receptor agonist ZP5461 suppresses food intake and body weight in male rats
Lauren M Stein, Lauren E McGrath, Rinzin Lhamo, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
October 27, 2021
Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowel
Johannes Reiner, Peggy Berlin, Jascha Held, et al.
Journal of Medicinal Chemistry
|
November 11, 2025
Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin Analogue
Henrik Fischer Munch, Rasmus Just, Jesper Mosolff Mathiesen, et al.
Page
of 1